First Advantage (FA) Research & Development (2020 - 2026)
First Advantage's (FA) quarterly Research & Development came in at $24.6 million in Q1 2026, down 9.39% YoY from $27.2 million in Q1 2025, and up 3.01% on a QoQ basis from $23.9 million in Q4 2025.
First Advantage (FA) Research & Development (2020 - 2026) Analysis & Trends
First Advantage (FA) has 7 years of Research & Development data on file, last reported at $24.6 million in Q1 2026.
- Quarterly Research & Development fell 9.39% year-over-year to $24.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.3 million (up 26.49% YoY) and the FY2025 annual result came in at $101.9 million, up 59.6% from the prior year.
- Research & Development improved to $24.6 million in Q1 2026, from $23.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $27.2 million in Q1 2025 to a low of $10.9 million in Q4 2023.
- A 5-year average of $17.1 million and a median of $13.2 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development surged 127.43% — and 2026, when it decreased 9.39%.
- Tracing FA's Research & Development over 5 years: stood at $12.0 million in 2022, then retreated by 8.97% to $10.9 million in 2023, then surged by 127.43% to $24.8 million in 2024, then slipped by 3.55% to $23.9 million in 2025, then advanced by 3.01% to $24.6 million in 2026.
- The last three Research & Development figures came in at $24.6 million (Q1 2026), $23.9 million (Q4 2025), and $25.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.52 Bn | 81.23 Bn | 1.48 Bn | - |
| 2 | Relx | 65.48 Bn | 65.30 Bn | - | - |
| 3 | Copart | 32.09 Bn | 28.73 Bn | 732.88 Mn | - |
| 4 | Global Payments | 25.02 Bn | 19.61 Bn | 2.03 Bn | - |
| 5 | Rb Global | 16.37 Bn | 15.84 Bn | 935.50 Mn | - |
| 6 | Aramark | 15.69 Bn | 15.19 Bn | 430.34 Mn | - |
| 7 | UL Solutions | 15.17 Bn | 14.74 Bn | 417.00 Mn | - |
| 8 | Rentokil Initial | 11.95 Bn | 9.43 Bn | - | - |
| 9 | Dolby Laboratories | 6.10 Bn | 5.43 Bn | 264.68 Mn | 85.07 Mn |
| 10 | First Advantage | 3.63 Bn | 3.39 Bn | 203.99 Mn | 27.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.27 Mn |
| Mar 31, 2026 | 24.61 Mn |
| Dec 31, 2025 | 23.89 Mn |
| Sep 30, 2025 | 25.14 Mn |
| Jun 30, 2025 | 25.68 Mn |
| Mar 31, 2025 | 27.16 Mn |
| Dec 31, 2024 | 24.77 Mn |
| Sep 30, 2024 | 12.91 Mn |
| Jun 30, 2024 | 13.68 Mn |
| Mar 31, 2024 | 12.47 Mn |
| Dec 31, 2023 | 10.89 Mn |
| Sep 30, 2023 | 13.11 Mn |
| Jun 30, 2023 | 12.64 Mn |
| Mar 31, 2023 | 12.62 Mn |
| Dec 31, 2022 | 11.96 Mn |
| Sep 30, 2022 | 13.25 Mn |
| Jun 30, 2022 | 12.95 Mn |
| Mar 31, 2022 | 13.77 Mn |
| Dec 31, 2021 | 11.96 Mn |
| Sep 30, 2021 | 11.31 Mn |